Carregant...
Comparison of (123)I-Metaiodobenzylguanidine (MIBG) and (131)I-MIBG Semi-Quantitative Scores in Predicting Survival in Patients With Stage 4 Neuroblastoma: A Report From the Children’s Oncology Group
BACKGROUND: (123)I-metaiodobenzylguanidine (MIBG) scans are preferable to (131)I-MIBG for neuroblastoma imaging as they deliver less patient radiation yet have greater sensitivity in disease detection. Both (123)I-MIBG and (131)I-MIBG scans were used for disease assessments of neuroblastoma patients...
Guardat en:
| Publicat a: | Pediatr Blood Cancer |
|---|---|
| Autors principals: | , , , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
2011
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4581540/ https://ncbi.nlm.nih.gov/pubmed/21328522 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/pbc.22991 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|